Evidence map›Paper›PMID 41562255›Full record

ArticleNucleic acids research2026

The two-step purification method ViREn identifies a single NSUN6-mediated 5-methylcytosine modification promoting dengue virus RNA genome turnover.

Chia Ching Wu, Isabel S Naarmann-de Vries, Jonas Hartmann, Zarina Nidoieva, Kevin Kopietz, Virginie Marchand, Zeynep Özrendeci, Doris Lindner, Sophia Schelchshorn, Sophia Flad and 10 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Chia Ching WuDepartment of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg University, Medical Faculty Heidelberg, 69120 Heidelberg, Germany.
Isabel S Naarmann-de VriesKlaus Tschira Institute for Integrative Computational Cardiology, Heidelberg University, Medical Faculty Heidelberg, 69120 Heidelberg, Germany.
Jonas HartmannDepartment of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg University, Medical Faculty Heidelberg, 69120 Heidelberg, Germany.
Zarina NidoievaInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
Kevin KopietzInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
Virginie MarchandUniversité de Lorraine, SMP IBSLor, EpiRNA-Seq Core Facility, 54000 Nancy, France.
Zeynep ÖzrendeciInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
Doris LindnerDivision of Biochemistry, Mannheim Institute for Innate Immunoscience (MI3) and Mannheim Cancer Center (MCC), Heidelberg University, Medical Faculty Mannheim, 68167 Mannheim, Germany.
Sophia SchelchshornDepartment of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg University, Medical Faculty Heidelberg, 69120 Heidelberg, Germany.
Sophia FladDivision of Mechanisms Regulating Gene Expression, German Cancer Research Center-Deutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
Michaela FryeDivision of Mechanisms Regulating Gene Expression, German Cancer Research Center-Deutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
F Nina PapavasiliouDivision of Immune Diversity, German Cancer Research Center-Deutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.ORCID 0000-0002-5971-7909
Tanja SchirmeisterInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
Georg StoecklinDivision of Biochemistry, Mannheim Institute for Innate Immunoscience (MI3) and Mannheim Cancer Center (MCC), Heidelberg University, Medical Faculty Mannheim, 68167 Mannheim, Germany.ORCID 0000-0001-9284-9834
Johanna SchottDivision of Biochemistry, Mannheim Institute for Innate Immunoscience (MI3) and Mannheim Cancer Center (MCC), Heidelberg University, Medical Faculty Mannheim, 68167 Mannheim, Germany.
Yuri MotorinUniversité de Lorraine, SMP IBSLor, EpiRNA-Seq Core Facility, 54000 Nancy, France.ORCID 0000-0002-8018-334X
Francesca TuortoDivision of Biochemistry, Mannheim Institute for Innate Immunoscience (MI3) and Mannheim Cancer Center (MCC), Heidelberg University, Medical Faculty Mannheim, 68167 Mannheim, Germany.ORCID 0000-0003-1625-1181
Christoph DieterichKlaus Tschira Institute for Integrative Computational Cardiology, Heidelberg University, Medical Faculty Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0001-9468-6311
Mark HelmInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.ORCID 0000-0002-0154-0928
Alessia RuggieriDepartment of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg University, Medical Faculty Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0001-9981-3308

Funding

Deutsche Forschungsgemeinschaft 439669440Deutsche Forschungsgemeinschaft 445549683French Grand Est Region ProjectHeidelberg University
6 · The paper itself

Abstract

Chemical modifications on cellular and viral RNAs are new layers of post-transcriptional regulation of cellular processes, including RNA stability and translation. Although advances in analytical methods have improved the detection of RNA modifications, precise mapping at single-base resolution remains challenging. Requirements for sensitivity and purity limit accuracy and reproducibility, especially for low abundant viral RNAs extracted from infected cells. Here, we report a two-step method, ViREn, for the enrichment of the genomic RNA (gRNA) of dengue virus (DENV), a positive-sense single-stranded RNA virus. This approach enabled the preparation of gRNA with significantly increased purity and led to the identification of a single high-confidence 5-methylcytosine (m5C) site in DENV gRNA at position 1218. This finding was orthogonally validated by Illumina-based bisulfite sequencing and by Nanopore Oxford Technologies direct RNA sequencing. Strikingly, m5C1218 was detected exclusively in gRNA extracted from infected cells but not in gRNA extracted from viral particles. We identified NSUN6 as the host methyltransferase catalyzing this modification and demonstrated a role for m5C in regulating DENV gRNA turnover. ViREn thus enables the mapping of m5C on low-abundance viral gRNA with unprecedented precision and sensitivity and facilitates future mechanistic studies into the role of RNA modifications in virus replication.

Indexed as

5-MethylcytosineDengue VirusGenome, ViralMethyltransferasesRNA, ViralHumansRNA MethylationtRNA Methyltransferases5-MethylcytosineMethyltransferasesNSUN6 protein, humanRNA, ViraltRNA Methyltransferases

Identifiers

PMID41562255
PMCPMC12820529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.